1215 related articles for article (PubMed ID: 18425917)
1. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; McNeil A; van Rumste MM
Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; Kang A; Woolner A
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD005289. PubMed ID: 25150465
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; Woolner A
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD005289. PubMed ID: 33844275
[TBL] [Abstract][Full Text] [Related]
4. Assisted reproductive technologies for male subfertility.
Cissen M; Bensdorp A; Cohlen BJ; Repping S; de Bruin JP; van Wely M
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD000360. PubMed ID: 26915339
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
6. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
7. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
[TBL] [Abstract][Full Text] [Related]
8. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198
[TBL] [Abstract][Full Text] [Related]
9. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046
[TBL] [Abstract][Full Text] [Related]
10. Natural cycle in vitro fertilisation (IVF) for subfertile couples.
Allersma T; Farquhar C; Cantineau AE
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD010550. PubMed ID: 23990351
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
[TBL] [Abstract][Full Text] [Related]
12. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
[TBL] [Abstract][Full Text] [Related]
13. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization.
Gibreel A; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2012 Nov; 11():CD008528. PubMed ID: 23152261
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.
Kalampokas T; Pandian Z; Keay SD; Bhattacharya S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004752. PubMed ID: 28349525
[TBL] [Abstract][Full Text] [Related]
15. Volume expanders for the prevention of ovarian hyperstimulation syndrome.
Youssef MA; Mourad S
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848
[TBL] [Abstract][Full Text] [Related]
16. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Maheshwari A; Vaidakis D; Bhattacharya S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006606. PubMed ID: 30480769
[TBL] [Abstract][Full Text] [Related]
17. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
18. In vitro fertilisation for unexplained subfertility.
Pandian Z; Bhattacharya S; Vale L; Templeton A
Cochrane Database Syst Rev; 2005 Apr; (2):CD003357. PubMed ID: 15846658
[TBL] [Abstract][Full Text] [Related]
19. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome.
Youssef MA; Al-Inany HG; Evers JL; Aboulghar M
Cochrane Database Syst Rev; 2011 Feb; (2):CD001302. PubMed ID: 21328249
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
